115 related articles for article (PubMed ID: 2164869)
1. Propranolol metabolism by isolated hepatocytes from normal and cirrhotic rat livers: the effect of albumin.
Gariepy L; Fenyves D; Petit JL; Raymond G; Villeneuve JP
Can J Physiol Pharmacol; 1990 Jun; 68(6):657-62. PubMed ID: 2164869
[TBL] [Abstract][Full Text] [Related]
2. Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat.
Wood AJ; Villeneuve JP; Branch RA; Rogers LW; Shand DG
Gastroenterology; 1979 Jun; 76(6):1358-62. PubMed ID: 437433
[TBL] [Abstract][Full Text] [Related]
3. Propranolol disposition in the rat: variation in hepatic extraction with unbound drug fraction.
Gariépy L; Fenyves D; Villeneuve JP
J Pharm Sci; 1992 Mar; 81(3):255-8. PubMed ID: 1640364
[TBL] [Abstract][Full Text] [Related]
4. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
[TBL] [Abstract][Full Text] [Related]
5. Increased sensitivity of propranolol clearance to reduced oxygen delivery in the isolated perfused cirrhotic rat liver.
Hickey PL; McLean AJ; Angus PW; Choo EF; Morgan DJ
Gastroenterology; 1996 Oct; 111(4):1039-48. PubMed ID: 8831600
[TBL] [Abstract][Full Text] [Related]
6. Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat.
Fenyves D; Gariépy L; Villeneuve JP
Hepatology; 1993 Feb; 17(2):301-6. PubMed ID: 8428728
[TBL] [Abstract][Full Text] [Related]
7. A carrier-protein receptor is not a prerequisite for avid hepatic elimination of highly bound compounds: a study of propranolol elimination by the isolated perfused rat liver.
Jones DB; Ching MS; Smallwood RA; Morgan DJ
Hepatology; 1985; 5(4):590-3. PubMed ID: 2991106
[TBL] [Abstract][Full Text] [Related]
8. Clearance by the liver in cirrhosis. II. Characterization of propranolol uptake with the multiple-indicator dilution technique.
Gariépy L; Fenyves D; Kassissia I; Villeneuve JP
Hepatology; 1993 Oct; 18(4):823-31. PubMed ID: 8406355
[TBL] [Abstract][Full Text] [Related]
9. Clearance by the liver in cirrhosis. III. Propranolol uptake by the isolated perfused human liver.
Villeneuve JP; Dagenais M; Huet PM; Lapointe R; Roy A; Marleau D
Can J Physiol Pharmacol; 1996 Dec; 74(12):1327-32. PubMed ID: 9047043
[TBL] [Abstract][Full Text] [Related]
10. In micronodular cirrhosis, hepatocytes retain a normal C-25 hydroxylation capacity toward vitamin D3: a study using the rat carbon tetrachloride-induced cirrhotic model.
Dubé C; Vallières S; Ethier C; Benbrahim N; Tremblay C; Gascon-Barré M
Hepatology; 1991 Mar; 13(3):489-99. PubMed ID: 1847894
[TBL] [Abstract][Full Text] [Related]
11. Effect of cirrhosis on sulphation by the isolated perfused rat liver.
Choo EF; Angus PW; Morgan DJ
J Hepatol; 1999 Mar; 30(3):498-502. PubMed ID: 10190735
[TBL] [Abstract][Full Text] [Related]
12. Investigation of albumin-synthesizing ability in rat cirrhotic liver-derived hepatocytes using primary hepatocyte culture.
Koura T; Kaneko S; Matsushita E; Ohno H; Kaji K; Kobayashi K
J Hepatol; 1999 Aug; 31(2):293-9. PubMed ID: 10453943
[TBL] [Abstract][Full Text] [Related]
13. Collagenase of hepatocytes and sinusoidal liver cells in the reversibility of experimental cirrhosis of the liver.
Montfort I; Pérez-Tamayo R; Alvizouri AM; Tello E
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(5):281-9. PubMed ID: 1980558
[TBL] [Abstract][Full Text] [Related]
14. Reduced hepatic clearance of propranolol induced by chronic carbon tetrachloride treatment in rats.
Iwamoto K; Watanabe J; Araki K; Satoh M; Deguchi N
J Pharmacol Exp Ther; 1985 Aug; 234(2):470-5. PubMed ID: 4020680
[TBL] [Abstract][Full Text] [Related]
15. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.
Jones DB; Morgan DJ; Mihaly GW; Webster LK; Smallwood RA
J Pharmacol Exp Ther; 1984 May; 229(2):522-6. PubMed ID: 6716274
[TBL] [Abstract][Full Text] [Related]
16. Liver function improvement following increased portal blood flow in cirrhotic rats.
Cardoso JE; Giroux L; Kassissia I; Houssin D; Habib N; Huet PM
Gastroenterology; 1994 Aug; 107(2):460-7. PubMed ID: 8039623
[TBL] [Abstract][Full Text] [Related]
17. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
Poulin P; Haddad S
J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent hepatic handling of l-propranolol determined by multiple indicator dilution method: influence of tissue binding of l-propranolol on its hepatic elimination.
Miyauchi S; Sawada Y; Iga T; Hanano M; Sugiyama Y
Biol Pharm Bull; 1993 Oct; 16(10):1019-24. PubMed ID: 8287031
[TBL] [Abstract][Full Text] [Related]
19. Effect of inflammation on the metabolism of antipyrine, lidocaine and propranolol in isolated rat hepatocytes.
Chindavijak B; Belpaire FM; Bogaert MG
Pharmacology; 1988; 36(4):279-82. PubMed ID: 3380881
[TBL] [Abstract][Full Text] [Related]
20. Altered transmembrane ionic flux in hepatocytes isolated from cirrhotic rats.
Burczynski FJ; Wang GQ; Minuk GY; Rosser B
J Hepatol; 1999 Mar; 30(3):492-7. PubMed ID: 10190734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
